Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 128:
129. The compound of claim 125, wherein the compound is of formula (II-A-1):, , or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof,
wherein:
R2 is pyridin-2(1H)-onyl, pyridinyl, indazol-4-yl, indazol-5-yl, indazol-6-yl, or indazol-7-yl;
wherein the pyridin-2(1H)-onyl is optionally substituted by 1, 2, or 3 independently selected R2c substituents; and
wherein the pyridinyl, indazol-4-yl, indazol-5-yl, indazol-6-yl, or indazol-7-yl is optionally substituted by 1, 2, 3, or 4 independently selected R2e substituents.